Novocure (NVCR) Stocks Surge 5.5% on 21 Oct: Market Value $1.7B, Analyst Praise
Novocure Limited (NVCR) hits a 5.5% rise to $15.81, trading strong despite a 4.96% monthly dip. Experts flag undervaluation as its oncology tech grows.
2 minutes to read
